ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,443,000 | +7.7% | 24,231 | +23.4% | 0.04% | +15.4% |
| Q2 2021 | $1,340,000 | -0.7% | 19,643 | +1.0% | 0.04% | -2.5% |
| Q1 2021 | $1,350,000 | -14.3% | 19,456 | -5.1% | 0.04% | -20.0% |
| Q4 2020 | $1,575,000 | -16.3% | 20,501 | -18.5% | 0.05% | -27.5% |
| Q3 2020 | $1,881,000 | +18.8% | 25,145 | 0.0% | 0.07% | +13.1% |
| Q2 2020 | $1,583,000 | +9.9% | 25,145 | -26.7% | 0.06% | -10.3% |
| Q1 2020 | $1,441,000 | +4.5% | 34,314 | +13.0% | 0.07% | +47.8% |
| Q4 2019 | $1,379,000 | -49.9% | 30,363 | -49.5% | 0.05% | -50.0% |
| Q3 2019 | $2,752,000 | -22.0% | 60,137 | 0.0% | 0.09% | -20.0% |
| Q2 2019 | $3,526,000 | +39.1% | 60,137 | +6.4% | 0.12% | +40.2% |
| Q1 2019 | $2,534,000 | +16.7% | 56,533 | +1.4% | 0.08% | +7.9% |
| Q4 2018 | $2,172,000 | -42.3% | 55,767 | -31.9% | 0.08% | -31.5% |
| Q3 2018 | $3,766,000 | +5.7% | 81,839 | +0.1% | 0.11% | +4.7% |
| Q2 2018 | $3,563,000 | +6.2% | 81,725 | -3.8% | 0.11% | -7.8% |
| Q1 2018 | $3,356,000 | – | 84,970 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |